CXCR3 expression elevated on peripheral CD8 + lymphocytes from HIV/HCV coinfected individuals

Viral Immunology

Volumn 24, Issue 6, 2011, Pages 441-448

  Kimball, Pam ^a   McDougan, Felecia ^a   Stirling, Richard ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; PHYTOHEMAGGLUTININ;

ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE FREQUENCY; GENETIC VARIABILITY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; MALE; MIXED INFECTION; PERIPHERAL LYMPHOCYTE;

CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CXCL10; COINFECTION; CULTURE MEDIA; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEPACIVIRUS; HEPATITIS C; HIV; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PHYTOHEMAGGLUTININS; RECEPTORS, CXCR3; RNA, VIRAL; TIME FACTORS;

EID: 83255166505     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2011.0035     Document Type: Article

References (31)

1. Apolinario A, Majano P, Lorente R, Nunez O, Clemente G, and Garcia-Monzon C: (2005). Gene expression profile of T cell specific chemokines in human hepatocyte-derived cells: evidence for a synergistic inducer effect of cytokines and hepatitis C virus proteins. J Viral Hepatitis 12:27-37. (Pubitemid 40188771)
2. Askarieh G, Alsio A, Pugnala P, et al.: (2010). Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C. Hepatology 51:1523-1530.
3. Asselah T, Bieche I, Laurendeau I, et al.: (2005). Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C. Gastroenterology: 129: 2064-75. (Pubitemid 41772981)
4. Blackard J, Komurian-Pradel F, Perret M, et al.: (2006). Intrahepatic cytokine expression is downregulated ring HCV/ HIV co-infection. J Med Virol 78:202-207. (Pubitemid 43132564)
5. Chen T, Ding E, Seage G, and Kim A: (2009). Meta-analysis: increased mortality associated with hepatitis C in HIVinfected persons is unrelated to HIV disease progression. Clin Infect Dis 49:1605-1615.
6. Harvey C, Post J, Palladinetti P, et al.: (2003). Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation. J Leukoc Biol 74:360-369. (Pubitemid 38040396)
7. Hokeness K, Deweerd E, Munks M, Lewis C, Gladue R, and Salazar-Mather T: (2007). CXR3 dependent recruitment of antigen specific T lymphocytes to the liver during murine cytomegalovirus infection. J Virol 81:1241-1250. (Pubitemid 46167845)
8. Kimball P, Shiffman M, and Verbeke S: (2002). Proliferative suppression and Class I insufficiency on peripheral blood cells from HCV patients overcome by exogenous cytokines or high dose mitogen. Clin Immunol 103:317-323. (Pubitemid 34666756)
9. Kuntzen T, Tural C, Li B, et al.: (2008). Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines and influence of HAART. AIDS 22:203-210.
10. Lagging M, Romero A, Westin J, et al.: (2006). IP10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection. Hepatology 44: 1617-1625. (Pubitemid 44953667)
11. Larrubia J, Benito-Martinez S, Calvino M, Sanz-de-Villalobos E, and Parra-Cid T: (2008). Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection. World J Gastroentrol 21:7149-7159.
12. Larrubia J, Calvino M, Benito S, Sanz-de-Villalobos E, Perna C, and Perez-Hornedo J: (2007). The role of CCR5/CXCR3 expressing CD8 + cells in liver damage and viral control during persistent hepatitis C virus infection. J Hepatol 47: 632-641. (Pubitemid 47503421)
13. Mindikoglu A, Regev A, and Magder L. (2008). Impact of human immunodeficiency virus on survival after liver transplantation: analysis of United Network for Organ Sharing database. Transplant 85:359-368. (Pubitemid 351322759)
14. Miro J, Laguno M, Moreno A, and Rimola A: (2006). Management of end stage liver disease (ESLD): what is the current role of orthotopic liver transplantation (OLT)? J Hepatol 44:S140-S145. (Pubitemid 43053890)
15. Oo Y, Weston C, Lalor P, et al.: (2010). Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver. J Immunol 184:2886-2898.
16. Perney P, Turriere C, Portales P, et al.: (2009). CXCR3 expression on peripheral CD4+ T cells as a predictive marker of response to treatment in chronic hepatitis C. Clin Immunol 132:55-62.
17. Petrovic L: (2007). HIV/HCV co-infection: histopathologic findings, natural history, fibrosis, and impact of antiretroviral treatment: a review article. Liver Int 27:598-596.
18. Rabin R, Alston M, Sircus J, et al.: (2003). CXCR3 is induced early on the pathway of CD4+ T cell differentiation and bridges central and peripheral functions. J Immunol 171:2812-2824. (Pubitemid 37093500)
19. Roe B, Coughlan S, Dean J, et al.: (2009). Phenotypic characterization of lymphocytes in HCV/HIV co-infected patients. Viral Immunol 22:39-47.
20. Roe B, Coughlan S, Hassan J, et al.: (2007). Elevated serum levels of interferon-c-inductible protein-10 in patients coinfected with hepatitis C virus and HIV. J Infect Dis 196: 1053-1057. (Pubitemid 47580300)
21. Rosenblum J, Shimoda N, Schenk A, et al.: (2010). CXC chemokine ligand (CXCL) 9 and CXCl10 are antagonistic costimulation molecules during the priming of alloreactive T cell effectors. J Immunol 184:3450-3460.
22. Samri A, Roque-Afonso A, Beran O, et al.: (2009). Preservation of immune function and anti-hepatitis C virus (HCV) immune responses after liver transplantation in HIV-HCV coninfected patients (ANRS-HC08 "THEVIC" trial). J Hepatol 51:1000-1009.
23. Schrage A, Wechsung K, Neumann K, et al.: (2008). Enhanced T cell transmigration across the murine liver sinusoidal endothelium is mediated by transcytosis and surface presentation of cytokines. Hepatology 48:1262-1272.
24. Singal A, and Anand B: (2009). Management of hepatitis C virus infection in HIV/HCV co-infected patients: clinical review. World J Gastroenterol 15:3713-3724.
25. Soriano V, Vispo E, Labarga P, Medrano J, and Barreiro S: (2010). Viral hepatitis and HIV co-infection. Antiviral Res 85:303-315.
26. Stacey A, Norris P, Qin L, et al.: (2009). Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol 83:3719-3733.
27. Sulkowski M, and Benhamou Y: (2007). Therapeutic issues in HIV/HCV-coinfected patients. J Viral Hepatitis 14: 371-386. (Pubitemid 46744053)
28. Zeremski M, Dimova R, Brown Q, Jacobson I, Markatou M, and Talal A. (2009). Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection. J Infect Dis 200:1774-1780.
29. Zeremski M, Maratou M, Brown Q, Dorante G, Cunningham-Rundles S, and Talal A: (2007). Interferon k-inducible protein 10: a predictive marker of successful treatment response in hepatitis C virus/HIV-coinfected patients. J Acquir Immune Defic Syndr 45:262-268. (Pubitemid 47012371)
30. Zeremski M, Petrovic L, Chiriboga L, et al.: (2008). Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C. Hepatology 48:1440-1450.
31. Zeremski M, Petrovic L, and Talal A: (2007). The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection. J Viral Hepatitis 14:675-687. (Pubitemid 47414927)